Detalles de la búsqueda
1.
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.
Front Immunol;
15: 1372193, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38812507
2.
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.
Vaccines (Basel);
11(10)2023 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37896930
3.
Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.
Front Immunol;
14: 1215893, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533867
4.
Notes from the Field: Scrub Typhus Outbreak - Los Lagos Region, Chile, January-February 2023.
MMWR Morb Mortal Wkly Rep;
72(27): 753-754, 2023 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410667
5.
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.
EBioMedicine;
91: 104563, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099842
6.
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors.
Hum Vaccin Immunother;
19(1): 2177066, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36864601
7.
Eco-epidemiology of rodent-associated trombiculid mites and infection with Orientia spp. in Southern Chile.
PLoS Negl Trop Dis;
17(1): e0011051, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634106
8.
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.
Elife;
112022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36226829
9.
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.
mBio;
13(4): e0142322, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946814
10.
Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial.
Vaccines (Basel);
10(7)2022 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891246
11.
Development of a New Genus-Specific Quantitative Real-Time PCR Assay for the Diagnosis of Scrub Typhus in South America.
Front Med (Lausanne);
9: 831045, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35573006
12.
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.
medRxiv;
2022 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441179
13.
Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY).
Open Forum Infect Dis;
9(3): ofab605, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35146039
14.
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile.
Clin Infect Dis;
75(1): e792-e804, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34537835
15.
Novel Vector of Scrub Typhus in Sub-Antarctic Chile: Evidence From Human Exposure.
Clin Infect Dis;
74(10): 1862-1865, 2022 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453514
16.
Detección del SARS-CoV-2 mediante RT-qPCR utilizando saliva en pacientes ambulatorios con estudio de COVID-19
Rev. chil. infectol;
39(4)2022.
Artículo
en Español
| LILACS-Express
| ID: biblio-1407808
17.
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Front Immunol;
12: 747830, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858404
18.
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
Front Immunol;
12: 742914, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659237
19.
Scrub typhus in Chile.
Cutis;
107(1): E35-E38, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651874
20.
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.
medRxiv;
2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441164